CDX2 and colorectal cancer: Colorectal cancer with negative CDX2 status (CDX2−) is associated with an increased likelihood of aggressive features such as lymph node metastasis (LNM), poor differentiation, lymphovascular (LVI), perineural (PNI) and extramural vascular (EMVI) invasion, BRAF mutation and CIMP12.